Cargando…
Chemokines and chemokine receptors required for optimal responses to anticancer chemotherapy
Depending on tumor type, stage and immunological contexture, the inhibition of chemokines or their receptors may yield positive or deleterious effects on disease progression. We have recently demonstrated in several murine models of anthracycline-based chemotherapy that the inhibition of chemokine (...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008453/ https://www.ncbi.nlm.nih.gov/pubmed/24800170 http://dx.doi.org/10.4161/onci.27663 |
_version_ | 1782314452664713216 |
---|---|
author | Ma, Yuting Adjemian, Sandy Galluzzi, Lorenzo Zitvogel, Laurence Kroemer, Guido |
author_facet | Ma, Yuting Adjemian, Sandy Galluzzi, Lorenzo Zitvogel, Laurence Kroemer, Guido |
author_sort | Ma, Yuting |
collection | PubMed |
description | Depending on tumor type, stage and immunological contexture, the inhibition of chemokines or their receptors may yield positive or deleterious effects on disease progression. We have recently demonstrated in several murine models of anthracycline-based chemotherapy that the inhibition of chemokine (C-C motif) ligand 2 (CCL2) or chemokine (C-C motif) receptor 2 (CCR2) may impair the elicitation of anticancer immune responses that contribute to therapeutic success. |
format | Online Article Text |
id | pubmed-4008453 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Landes Bioscience |
record_format | MEDLINE/PubMed |
spelling | pubmed-40084532014-05-05 Chemokines and chemokine receptors required for optimal responses to anticancer chemotherapy Ma, Yuting Adjemian, Sandy Galluzzi, Lorenzo Zitvogel, Laurence Kroemer, Guido Oncoimmunology Author's View Depending on tumor type, stage and immunological contexture, the inhibition of chemokines or their receptors may yield positive or deleterious effects on disease progression. We have recently demonstrated in several murine models of anthracycline-based chemotherapy that the inhibition of chemokine (C-C motif) ligand 2 (CCL2) or chemokine (C-C motif) receptor 2 (CCR2) may impair the elicitation of anticancer immune responses that contribute to therapeutic success. Landes Bioscience 2014-01-10 /pmc/articles/PMC4008453/ /pubmed/24800170 http://dx.doi.org/10.4161/onci.27663 Text en Copyright © 2014 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited. |
spellingShingle | Author's View Ma, Yuting Adjemian, Sandy Galluzzi, Lorenzo Zitvogel, Laurence Kroemer, Guido Chemokines and chemokine receptors required for optimal responses to anticancer chemotherapy |
title | Chemokines and chemokine receptors required for optimal responses to anticancer chemotherapy |
title_full | Chemokines and chemokine receptors required for optimal responses to anticancer chemotherapy |
title_fullStr | Chemokines and chemokine receptors required for optimal responses to anticancer chemotherapy |
title_full_unstemmed | Chemokines and chemokine receptors required for optimal responses to anticancer chemotherapy |
title_short | Chemokines and chemokine receptors required for optimal responses to anticancer chemotherapy |
title_sort | chemokines and chemokine receptors required for optimal responses to anticancer chemotherapy |
topic | Author's View |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008453/ https://www.ncbi.nlm.nih.gov/pubmed/24800170 http://dx.doi.org/10.4161/onci.27663 |
work_keys_str_mv | AT mayuting chemokinesandchemokinereceptorsrequiredforoptimalresponsestoanticancerchemotherapy AT adjemiansandy chemokinesandchemokinereceptorsrequiredforoptimalresponsestoanticancerchemotherapy AT galluzzilorenzo chemokinesandchemokinereceptorsrequiredforoptimalresponsestoanticancerchemotherapy AT zitvogellaurence chemokinesandchemokinereceptorsrequiredforoptimalresponsestoanticancerchemotherapy AT kroemerguido chemokinesandchemokinereceptorsrequiredforoptimalresponsestoanticancerchemotherapy |